PortfoliosLab logoPortfoliosLab logo
PCOR vs. INSM
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PCOR vs. INSM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Procore Technologies, Inc. (PCOR) and Insmed Incorporated (INSM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PCOR achieves a -30.37% return, which is significantly higher than INSM's -40.32% return.


PCOR

1D
-3.89%
1M
-18.44%
YTD
-30.37%
6M
-33.29%
1Y
-24.78%
3Y*
-7.10%
5Y*
-9.02%
10Y*

INSM

1D
0.13%
1M
-25.82%
YTD
-40.32%
6M
-49.77%
1Y
42.12%
3Y*
74.52%
5Y*
32.61%
10Y*
24.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PCOR vs. INSM - Yearly Performance Comparison


2026 (YTD)20252024202320222021
PCOR
Procore Technologies, Inc.
-30.37%-2.92%8.25%46.71%-41.00%-9.13%
INSM
Insmed Incorporated
-40.32%152.09%122.78%55.11%-26.65%3.69%

Correlation

The correlation between PCOR and INSM is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (All Time)
Calculated using the full available price history since May 21, 2021

0.29

The correlation between PCOR and INSM shifts across timeframes, from -0.03 (1 year) to 0.29 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

PCOR:

$7.65B

INSM:

$22.38B

EPS

PCOR:

-$0.51

INSM:

-$5.71

PS Ratio

PCOR:

5.56

INSM:

26.29

PB Ratio

PCOR:

6.37

INSM:

31.75

Total Revenue (TTM)

PCOR:

$1.37B

INSM:

$819.56M

Gross Profit (TTM)

PCOR:

$1.09B

INSM:

$668.55M

EBITDA (TTM)

PCOR:

$3.80M

INSM:

-$1.14B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PCOR vs. INSM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PCOR
PCOR Risk / Return Rank: 1919
Overall Rank
PCOR Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
PCOR Sortino Ratio Rank: 2020
Sortino Ratio Rank
PCOR Omega Ratio Rank: 2020
Omega Ratio Rank
PCOR Calmar Ratio Rank: 2020
Calmar Ratio Rank
PCOR Martin Ratio Rank: 1414
Martin Ratio Rank

INSM
INSM Risk / Return Rank: 6262
Overall Rank
INSM Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
INSM Sortino Ratio Rank: 6262
Sortino Ratio Rank
INSM Omega Ratio Rank: 6868
Omega Ratio Rank
INSM Calmar Ratio Rank: 5858
Calmar Ratio Rank
INSM Martin Ratio Rank: 5959
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PCOR vs. INSM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Procore Technologies, Inc. (PCOR) and Insmed Incorporated (INSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PCORINSMDifference
Sharpe ratioReturn per unit of total volatility

-1.24

Sortino ratioReturn per unit of downside risk

-1.86

Omega ratioGain probability vs. loss probability

0.94

1.22

-0.28

Calmar ratioReturn relative to maximum drawdown

-0.59

0.81

-1.40

Martin ratioReturn relative to average drawdown

-1.20

1.93

-3.13

PCOR vs. INSM - Sharpe Ratio Comparison

The current PCOR Sharpe Ratio is -0.52, which is lower than the INSM Sharpe Ratio of 0.73. The chart below compares the historical Sharpe Ratios of PCOR and INSM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PCORINSMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.52

0.73

-1.24

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.18

0.45

-0.64

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.31

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.21

-0.02

-0.19

Drawdowns

PCOR vs. INSM - Drawdown Comparison

The maximum PCOR drawdown since its inception was -61.70%, smaller than the maximum INSM drawdown of -98.65%. Use the drawdown chart below to compare losses from any high point for PCOR and INSM.


Loading charts...

Drawdown Indicators


PCORINSMDifference

Max Drawdown

Largest peak-to-trough decline

-61.70%

-98.65%

+36.95%

Max Drawdown (1Y)

Largest decline over 1 year

-42.22%

-52.06%

+9.84%

Max Drawdown (3Y)

Largest decline over 3 years

-47.93%

-52.06%

+4.13%

Max Drawdown (5Y)

Largest decline over 5 years

-61.70%

-52.06%

-9.64%

Max Drawdown (10Y)

Largest decline over 10 years

-64.84%

Current Drawdown

Current decline from peak

-52.19%

-50.87%

-1.32%

Average Drawdown

Average peak-to-trough decline

-36.74%

-86.12%

+49.38%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.62%

21.89%

-1.27%

Volatility

PCOR vs. INSM - Volatility Comparison

The current volatility for Procore Technologies, Inc. (PCOR) is 21.24%, while Insmed Incorporated (INSM) has a volatility of 30.56%. This indicates that PCOR experiences smaller price fluctuations and is considered to be less risky than INSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PCORINSMDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.24%

30.56%

-9.32%

Volatility (6M)

Calculated over the trailing 6-month period

39.17%

43.84%

-4.67%

Volatility (1Y)

Calculated over the trailing 1-year period

48.31%

58.25%

-9.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

49.29%

72.66%

-23.37%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.31%

78.47%

-29.16%

Dividends

PCOR vs. INSM - Dividend Comparison

Neither PCOR nor INSM has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

PCOR vs. INSM - Financials Comparison

This section allows you to compare key financial metrics between Procore Technologies, Inc. and Insmed Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M20222023202420252026
359.28M
305.96M
(PCOR) Total Revenue
(INSM) Total Revenue
Values in USD except per share items

PCOR vs. INSM - Profitability Comparison

The chart below illustrates the profitability comparison between Procore Technologies, Inc. and Insmed Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

74.0%76.0%78.0%80.0%82.0%84.0%20222023202420252026
80.1%
84.5%
Portfolio components
PCOR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Procore Technologies, Inc. reported a gross profit of 287.79M and revenue of 359.28M. Therefore, the gross margin over that period was 80.1%.

INSM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Insmed Incorporated reported a gross profit of 258.54M and revenue of 305.96M. Therefore, the gross margin over that period was 84.5%.

PCOR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Procore Technologies, Inc. reported an operating income of -15.67M and revenue of 359.28M, resulting in an operating margin of -4.4%.

INSM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Insmed Incorporated reported an operating income of -198.20M and revenue of 305.96M, resulting in an operating margin of -64.8%.

PCOR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Procore Technologies, Inc. reported a net income of -9.10M and revenue of 359.28M, resulting in a net margin of -2.5%.

INSM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Insmed Incorporated reported a net income of -163.56M and revenue of 305.96M, resulting in a net margin of -53.5%.


Frequently Asked Questions


PCOR and INSM have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INSM has higher volatility (30.56%) compared to PCOR (21.24%). In terms of maximum drawdown, PCOR dropped -61.70% vs INSM's -98.65%.

INSM currently has the higher Sharpe Ratio (0.73 vs -0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PCOR and INSM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer